TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis

Completed · Phase 2

Conditions studied: Tuberculosis

In brief

Randomized, double-blind study of the tolerability of three different doses of rifapentine

Key facts

Study ID

NCT00023426

Run by

Centers for Disease Control and Prevention

People needed

150

Starts

1999-07-01

Expected to finish

2003-02-01

Last updated by the study team

2005-09-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Central Arkansas Veterans Health System — Little Rock, Arkansas, United States
• LA County/USC Medical Center — Los Angeles, California, United States
• University of California, San Francisco — San Francisco, California, United States
• Denver Department of Public Health and Hospitals — Denver, Colorado, United States
• Washington, D.C. VAMC — Washington D.C., District of Columbia, United States
• Chicago VA Medical Center (Lakeside) — Chicago, Illinois, United States
• Hines VA Medical Center — Hines, Illinois, United States
• Johns Hopkins University School of Medicine — Baltimore, Maryland, United States
• Boston Medical Center — Boston, Massachusetts, United States
• New Jersey Medical School — Newark, New Jersey, United States
• New York University School of Medicine — New York, New York, United States
• Columbia University/Presbyterian Medical Center — New York, New York, United States
• Harlem Hospital Center — New York, New York, United States
• Carolinas Medical Center — Charlotte, North Carolina, United States
• Duke University Medical Center — Durham, North Carolina, United States
• Nashville VA Medical Center — Nashville, Tennessee, United States
• University of North Texas Health Science Center — Fort Worth, Texas, United States
• Thomas Street Clinic — Houston, Texas, United States
• Audi L. Murphy VA Hospital — San Antonio, Texas, United States
• Seattle King County Health Department — Seattle, Washington, United States
• University of British Columbia — Vancouver, British Columbia, Canada
• University of Manitoba — Winnipeg, Manitoba, Canada
• Montreal Chest Institute McGill University — Montreal, Quebec, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.